Despite a wealth of tools and therapies to effectively diagnose and treat COPD, this major healthcare burden remains the third leading cause of death in the United States. Studies indicate that COPD is often undiagnosed in primary care practices—even in patients with major COPD risk factors. Significant opportunities exist to greatly improve screening and diagnosis, including spirometry, which continues to be underused or incorrectly used. Nurse practitioners (NPs) and physician assistants (PAs) are in a unique position to drive these improvements. The new 2017 GOLD guidelines for managing COPD provide a current roadmap to help practitioners toward that goal.
Audio-enhanced slide lecture
Apply new guidelines and best practices in COPD to ensure all patients are appropriately screened, diagnosed, and treated, ultimately improving quality of care and reducing morbidity and mortality.
After completing this activity, participants should be better able to:
- Identify patient risk factors and diagnostic clues that suggest COPD
- Use validated clinical tools, including spirometry, to confirm COPD, assess symptom severity, and complete risk stratification
- Develop guideline-based treatment strategies to minimize exacerbations and hospitalizations
NPs and PAs
Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly provided by Practicing Clinicians Exchange.
Contact hours: 1.0, which are eligible for 1.0 pharmacology credits.
Course director: Jason Worcester, MD, Boston University School of Medicine
CNE course advisor: Claire Murphy, MSN, NP-C, Boston University School of Medicine
This program has been reviewed and is approved for a maximum of 1.00 hour(s) of AAPA Category 1 CME credit by the PA Review Panel. Approval is valid for 1 year from the issue date of December 30, 2016. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA's CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This educational activity is supported by an educational grant from GlaxoSmithKline.
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of Boston University School of Medicine, Continuing Education Alliance, Practicing Clinicians Exchange, or any educational supporter.
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices is being discussed.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration.
Dr Carlin: advisory board: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Monaghan, Nonin, Phillips Respironics, Sunovion; speaker: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Monaghan, Sunovion.
Ms Garvey: speaker: Boehringer Ingelheim.
The Planning Committee for this activity included Claire Murphy, MSN, NP-C, Jody Walker, MS, Julie L. White, MS, and Jason Worcester, MD, of Boston University School of Medicine; Patti-Ann Collins, DNP, MSN, MBA, RN (Lead Nurse Planner), of Healthcare Advocacy Services; Mark Christiansen, PhD, PA-C, of University of the Pacific; and Ruth Cohen and Warren Beckman of Practicing Clinicians Exchange. None of the aforementioned members of the Planning Committee have any significant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Listen to the presentation and study the program slides
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: December 30, 2016
Expiration date: December 29, 2017
COURSE VIEWING REQUIREMENTS
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, or Windows 7, 8, or 10
Google Chrome 18.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
Safari 4.0+ for Mac OSX 10.5+
© 2018 Practicing Clinicians Exchange. All Rights Reserved. GSPCE90116